Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Have $1,000? This Beaten-Down Biotech Has 4 Phase 3 Obesity Trials Underway.

Key PointsViking Therapeutics has four phase 3 obesity trials underway for VK2735.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Every outlet that reported this, and when →

Read the original at nasdaq.com →

More in Health & Medicine

More from Wednesday 18 November →